Complement activation in chronic liver disease.

LE Munoz, D De Villiers, D Markham… - Clinical and …, 1982 - ncbi.nlm.nih.gov
LE Munoz, D De Villiers, D Markham, K Whaley, HC Thomas
Clinical and Experimental Immunology, 1982ncbi.nlm.nih.gov
Patients with HBsAg positive chronic active liver disease (CALD) and primary biliary
cirrhosis (PBC) exhibit increased C3d concentrations and changes in the serum
concentrations of the complement components consistent with activation of the classical and
alternative pathways. In these patients the concentrations of the regulatory proteins, C3b
inactivator (C3bINA) and beta IH globulin, are normal. Patients with HBsAg negative CALD
and alcohol induced liver disease (ALD) exhibit no evidence of an increased level of …
Abstract
Patients with HBsAg positive chronic active liver disease (CALD) and primary biliary cirrhosis (PBC) exhibit increased C3d concentrations and changes in the serum concentrations of the complement components consistent with activation of the classical and alternative pathways. In these patients the concentrations of the regulatory proteins, C3b inactivator (C3bINA) and beta IH globulin, are normal. Patients with HBsAg negative CALD and alcohol induced liver disease (ALD) exhibit no evidence of an increased level of complement system activation. In these patients diminished serum concentrations of complement components appear to be related to diminished hepatic synthetic function. C4 synthesis may be specifically reduced in autoimmune chronic active liver disease.
ncbi.nlm.nih.gov